The global coronary stent market is projected to experience consistent growth in the coming years, fueled by the increasing adoption of minimally invasive procedures for treating coronary artery disease (CAD). According to a recent industry report, the market, valued at USD 9.63 billion in 2023, is expected to reach USD 12.49 billion by 2031, reflecting a compound annual growth rate (CAGR) of 3.3% over the forecast period (2024-2031).

Key Players

Some major key players in Coronary Stent Market are Abbott, Boston Scientific Corporation, Medtronic, B Braun Melsungen AG, Boston Scientific Corporation, Stentys SA, MicroPort Scientific Corporation, Terumo Corporation, Biotronik, Cook Medical, C. R. Bard, Inc. and other players.

Report Scope and Market Analysis:

This comprehensive report provides a detailed analysis of the coronary stent market, including:

• Market Segmentation: Categorization by stent type (bare-metal stents, drug-eluting stents, bioresorbable stents) and application area (acute coronary syndrome, elective percutaneous coronary intervention (PCI)).
• Regional Market Analysis: Identification of key geographic markets and their growth potential based on factors like prevalence of CAD, healthcare infrastructure, and adoption of minimally invasive procedures.
• Competitive Landscape: Profiling of leading manufacturers of coronary stents worldwide.

KEY MARKET SEGMENTATION

By Type

• Bioabsorbable Stents

• Bare-metal Coronary Stents

• Drug-eluting Stents

By Biomaterial

• Natural biomaterials

• Polymers biomaterials

• Metallic biomaterials

By End Users

• Ambulatory Surgical Centers

• Hospitals

• Other

Emerging Trends and Opportunities:

The report highlights several promising trends shaping the future of the coronary stent market:

• Focus on Advanced Stent Technologies: Development of next-generation stents with improved biocompatibility, reduced risk of restenosis (re-narrowing of the artery), and shorter deployment times.
• Continued Preference for Drug-Eluting Stents: Continued preference for drug-eluting stents due to their effectiveness in preventing restenosis compared to bare-metal stents.
• Minimally Invasive Procedure Advantages: Rising awareness of the benefits of minimally invasive procedures like PCI compared to bypass surgery, driving demand for coronary stents.
• Emerging Markets: Increasing healthcare infrastructure development and rising disposable income in emerging economies are expected to fuel market growth.

Challenges and Considerations:

While the market exhibits growth potential, the report acknowledges certain challenges that need to be addressed:

• High Cost of Stents: High cost of advanced stents and associated procedures, particularly in regions with limited healthcare resources.
• Focus on Cost-Effectiveness: Developing cost-effective stents and ensuring wider patient access through improved healthcare reimbursement policies.
• Complications Associated with Stents: Minimizing the risk of stent thrombosis (blood clot formation) and other potential complications associated with stent implantation.
• Stringent Regulatory Requirements: Navigating stringent regulatory processes for market approval of new stent technologies.

Key Takeaways:

The report offers valuable insights for stakeholders in the coronary stent market:

• The market is driven by the growing prevalence of CAD, advancements in stent technology, and the increasing adoption of minimally invasive procedures.
• Innovation in stent design, focus on cost-effectiveness, and improved patient outcomes are crucial for market growth.
• Addressing affordability concerns, minimizing complications, and navigating regulatory hurdles are essential challenges to overcome.

Recent Developments:

The report explores recent advancements in the market, such as:

• Development of bioresorbable stents that dissolve over time, potentially reducing the long-term risk of complications.
• Advancements in stent delivery systems for improved accuracy and ease of stent placement during PCI procedures.
• Growing interest in drug-coated balloons as an alternative to stents for certain patients.

Other Trending Report

Diabetic Ulcer Treatment Market Share

Telerehabilitation Market Share

Coronary Stent Market Share

Anesthesia Equipment Market Share

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

[email protected]

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.snsinsider.com